A detailed history of Citigroup Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Citigroup Inc holds 1,544,362 shares of AZN stock, worth $102 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,544,362
Previous 1,435,745 7.57%
Holding current value
$102 Million
Previous $112 Million 7.47%
% of portfolio
0.07%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.67 - $87.62 $8.33 Million - $9.52 Million
108,617 Added 7.57%
1,544,362 $120 Million
Q2 2024

Aug 12, 2024

BUY
$66.81 - $80.83 $38.1 Million - $46.1 Million
570,510 Added 65.94%
1,435,745 $112 Million
Q1 2024

May 10, 2024

BUY
$61.03 - $69.57 $12 Million - $13.7 Million
196,291 Added 29.34%
865,235 $58.6 Million
Q4 2023

Feb 09, 2024

SELL
$61.89 - $69.28 $3.96 Million - $4.43 Million
-63,977 Reduced 8.73%
668,944 $45.1 Million
Q3 2023

Nov 09, 2023

BUY
$64.85 - $71.7 $3.47 Million - $3.84 Million
53,536 Added 7.88%
732,921 $49.6 Million
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $39 Million - $42.3 Million
-558,120 Reduced 45.1%
679,385 $48.6 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $19.3 Million - $21.9 Million
305,420 Added 32.77%
1,237,505 $85.9 Million
Q4 2022

Feb 09, 2023

BUY
$54.21 - $70.44 $22.6 Million - $29.4 Million
417,526 Added 81.14%
932,085 $63.2 Million
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $7.69 Million - $19.7 Million
145,093 Added 39.27%
514,559 $28.2 Million
Q2 2022

Aug 10, 2022

SELL
$59.26 - $71.14 $10.9 Million - $13 Million
-183,275 Reduced 33.16%
369,466 $24.4 Million
Q1 2022

May 12, 2022

BUY
$55.72 - $67.12 $2.98 Million - $3.59 Million
53,529 Added 10.72%
552,741 $36.7 Million
Q4 2021

Feb 10, 2022

SELL
$54.02 - $63.83 $11.6 Million - $13.7 Million
-214,886 Reduced 30.09%
499,212 $29.1 Million
Q3 2021

Nov 10, 2021

BUY
$55.56 - $60.79 $39.7 Million - $43.4 Million
714,098 New
714,098 $42.9 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.